OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study
Jingwen Ai, Yi Zhang, Haocheng Zhang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 639-647
Open Access | Times Cited: 41
Jingwen Ai, Yi Zhang, Haocheng Zhang, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 639-647
Open Access | Times Cited: 41
Showing 26-50 of 41 citing articles:
Proteomic and cellular characterization of Omicron breakthrough infections and a third homologous or heterologous boosting vaccination in a longitudinal cohort
Yi Zhang, Zhangfan Fu, Haocheng Zhang, et al.
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 6, pp. 100769-100769
Open Access | Times Cited: 1
Yi Zhang, Zhangfan Fu, Haocheng Zhang, et al.
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 6, pp. 100769-100769
Open Access | Times Cited: 1
Comparable antigen-specific T cell responses in vaccinees with diverse humoral immune responses after the primary and booster BBIBP-CorV vaccination
Dong Wei, Yingying Chen, Xiaoqi Yu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2474-2484
Open Access | Times Cited: 6
Dong Wei, Yingying Chen, Xiaoqi Yu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2474-2484
Open Access | Times Cited: 6
A systematic review of current status and challenges of vaccinating children against SARS-CoV-2
Mengxin Zhang, Pin Zhang, Ying Liang, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 11, pp. 1212-1224
Open Access | Times Cited: 6
Mengxin Zhang, Pin Zhang, Ying Liang, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 11, pp. 1212-1224
Open Access | Times Cited: 6
Neutralizing Antibodies as Predictors of Vaccine Breakthrough Infection in Healthcare Workers Vaccinated with or without a Heterologous Booster Dose: A Cohort Study during the Third COVID-19 Wave in Peru
Miguel Hueda-Zavaleta, Juan Carlos Gómez de la Torre, José Alonso Cáceres-DelAguila, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 447-447
Open Access | Times Cited: 3
Miguel Hueda-Zavaleta, Juan Carlos Gómez de la Torre, José Alonso Cáceres-DelAguila, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 447-447
Open Access | Times Cited: 3
Humoral response after a BNT162b2 heterologous third dose of COVID-19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru
Stephanie Montero, Diego Urrunaga‐Pastor, Percy Soto-Becerra, et al.
Vaccine X (2023) Vol. 14, pp. 100311-100311
Open Access | Times Cited: 3
Stephanie Montero, Diego Urrunaga‐Pastor, Percy Soto-Becerra, et al.
Vaccine X (2023) Vol. 14, pp. 100311-100311
Open Access | Times Cited: 3
Reactogenicity, immunogenicity, and humoral immune response dynamics after the third dose of heterologous COVID-19 vaccines in participants fully vaccinated with inactivated vaccine
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 12, pp. 1873-1881
Closed Access | Times Cited: 5
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 12, pp. 1873-1881
Closed Access | Times Cited: 5
Effectiveness and waning of protection with different SARS-CoV-2 primary and booster vaccines during the Delta pandemic wave in 2021 in Hungary (HUN-VE 3 study)
Zoltán Vokó, Zoltán Kiss, György Surján, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Zoltán Vokó, Zoltán Kiss, György Surján, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Effectiveness of a third dose of COVID-19 vaccines against delta variant of SARS-COV-2: A Serbian cohort study
Nataša Djordjević, Sanja Matić, Dragan Milovanović, et al.
Srpski arhiv za celokupno lekarstvo (2023) Vol. 151, Iss. 9-10, pp. 518-524
Open Access | Times Cited: 2
Nataša Djordjević, Sanja Matić, Dragan Milovanović, et al.
Srpski arhiv za celokupno lekarstvo (2023) Vol. 151, Iss. 9-10, pp. 518-524
Open Access | Times Cited: 2
Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis
Haoyue Cheng, Zhicheng Peng, Shuting Si, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1101-1101
Open Access | Times Cited: 2
Haoyue Cheng, Zhicheng Peng, Shuting Si, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1101-1101
Open Access | Times Cited: 2
Efficacy of Heterologous Boosting Using Recombinant SARS-CoV-2 Fusion Protein Vaccine: A Randomized, Double-Blind and Placebo-Controlled Phase III Trial
Xuanyi Wang, Syed Faisal Mahmood, Fang Jin, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 1
Xuanyi Wang, Syed Faisal Mahmood, Fang Jin, et al.
SSRN Electronic Journal (2022)
Closed Access | Times Cited: 1
Immunogenicity and safety of different platforms of COVID‐19 vaccines given as a third (booster) dose in healthy adults
Zemin Lin, Mengnan Cheng, Fenghua Zhu, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4047-4052
Open Access | Times Cited: 1
Zemin Lin, Mengnan Cheng, Fenghua Zhu, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4047-4052
Open Access | Times Cited: 1
Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (Covovax™) after homologous and heterologous two-dose regimens
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Sitthichai Kanokudom, Jira Chansaenroj, Nungruthai Suntronwong, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Respuesta inmunitaria anti-SARS-CoV-2: Infección Natural vs. Vacunación
Maura J Petro Oropeza, Samuel Rodríguez Sanchez, Carlos Sanchez Fuentes, et al.
Revista Digital de Postgrado (2023) Vol. 12, Iss. 1
Open Access
Maura J Petro Oropeza, Samuel Rodríguez Sanchez, Carlos Sanchez Fuentes, et al.
Revista Digital de Postgrado (2023) Vol. 12, Iss. 1
Open Access
Immunogenicity and safety of a booster COVID‐19 vaccination in patients with chronic liver disease: A multicenter study
Jitao Wang, Jingwen Ai, Huiling Xiang, et al.
Portal hypertension & cirrhosis (2023) Vol. 2, Iss. 3, pp. 127-135
Open Access
Jitao Wang, Jingwen Ai, Huiling Xiang, et al.
Portal hypertension & cirrhosis (2023) Vol. 2, Iss. 3, pp. 127-135
Open Access
Side effects of vaccines
Stephanie Tom-Brophy, Alexander Konopnicki, Andrew W. Ambler, et al.
Side effects of drugs annual (2023), pp. 303-335
Closed Access
Stephanie Tom-Brophy, Alexander Konopnicki, Andrew W. Ambler, et al.
Side effects of drugs annual (2023), pp. 303-335
Closed Access
Immunogenicity Persistence of a Third-Dose Homologous BBIBP-CorV/CoronaVac Boosting Vaccination: A Prospective Open-Label Study
Na Ren, Zhihong Wang, Sikang Gao
Viral Immunology (2023) Vol. 37, Iss. 1, pp. 16-23
Closed Access
Na Ren, Zhihong Wang, Sikang Gao
Viral Immunology (2023) Vol. 37, Iss. 1, pp. 16-23
Closed Access
